Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,088,801
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Musunuri Shankar −$1.1M Chief Executive Officer sold 51% of stake
Date Insider Transaction Shares Price Value Owned after
2024-11-26 Fernandes Prabhavathi Director Purchase +10,000 $0.91 $9K 10,000
2024-06-28 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +66,929 66,929
2023-06-09 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +112,205 112,205
2022-06-07 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +140,091 140,091
2021-12-16 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +16,335 16,335
2021-05-25 Fernandes Prabhavathi Director Option exercise +19,500 $0.28 $5K 19,500
2021-05-25 Fernandes Prabhavathi Director Sale −19,500 $8.21 $160K 0
2021-05-25 Fernandes Prabhavathi Director Option exercise +14,000 $1.83 $26K 14,000
2021-05-25 Fernandes Prabhavathi Director Sale −14,000 $8.19 $115K 0
2021-05-25 Fernandes Prabhavathi Director Option exercise · Option (Right to Buy) −19,500 34,500
2021-05-25 Fernandes Prabhavathi Director Option exercise · Option (Right to Buy) −14,000 112,000
2021-01-01 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +126,000 126,000
2020-04-05 Fernandes Prabhavathi Director Grant or award · Option (Right to Buy) +54,000 54,000

Page 1 of 1 · 13 trades